Why omega-3 is the most plausible capsule on the shelf
Of all the supplements sold for psoriasis, fish oil has the best story. Psoriasis is a chronic inflammatory disease [2], omega-3 fats are studied for their part in inflammation, and people with psoriasis carry a higher burden of the heart and metabolic conditions that fish oil is separately studied for [3]. It is also the supplement with the most reported benefit: in the National Psoriasis Foundation's survey of 1206 members, 44.6% of those who had added fish oil or omega-3 reported skin improvement, behind only removing alcohol, gluten and nightshades [4].
A plausible mechanism and a widely held belief are the two things that make a claim worth testing, and unlike most psoriasis food claims, this one has been tested many times.
Sources for this section: [4] Dietary Behaviors in Psoriasis: Patient-Reported Outcomes from a U.S. National Survey
Eighteen trials, and a line down the middle
A 2020 systematic review pooled eighteen randomised trials of fish oil and its components in psoriasis. As monotherapy, fish oil or omega-3 had no effect on the severity index, on lesion area, or on itch. Combined with conventional treatments, it did: the severity index fell by a mean difference of -3.92, with a confidence interval from -6.15 to -1.69, and lesion area fell by a mean difference of -30. Safety evaluation suggested no between-group differences. The review also found that fish oil reduced certain risk factors for obesity, cardiovascular disease and metabolic disease in people with psoriasis, and regulated several inflammatory mediators [3]. Its conclusion was careful: when combined with conventional treatments, fish oil and its components may have beneficial effects on psoriasis and its comorbidities [3].
That split is the whole page. Fish oil on its own was measured as doing nothing. Fish oil alongside conventional treatment was measured as lowering severity on top of what the treatment did. The review does not explain why the two settings differ, and its pooled figure is an average across trials that combined the oil with different treatments; what it reports is a direction in the combined setting and no between-group safety difference.
Sources for this section: [3] Efficacy of fish oil and its components in the management of psoriasis: a systematic review of 18 randomized controlled trials
What the newer pooled analysis adds, and does not
The 2025 network meta-analysis of supplements in plaque psoriasis pooled twenty-one trials across vitamin D, XP-828L, fish oil, selenium, probiotics, curcumin and micronutrients. Its headline severity result belonged to vitamin D; fish oil was in the network without a headline of its own. The review's overall verdict was that no supplement dominated across outcomes, that adverse events were comparable across all of them, and that the certainty of the evidence was low to moderate because of heterogeneity and imprecision, with larger confirmatory trials and standardised dosing still needed [7].
So the newest synthesis neither overturns the 2020 review nor strengthens it. It leaves fish oil where the earlier review put it: a possible adjunct, not established, with no between-group difference in adverse events reported in either synthesis.
Sources for this section: [7] Effectiveness and safety of dietary supplements in the adjunctive treatment of psoriasis: a systematic review and network meta-analysis
Why 44.6% believed it and the monotherapy trials did not
The gap between the survey and the trials is worth sitting with, because it is the gap every psoriasis supplement lives in. Nearly half of the people who added fish oil reported their skin improved [4]. The pooled monotherapy trials found no effect on severity, lesion area or itch [3]. Both findings are real. The survey measured what people concluded from their own skin after starting something they expected to help; the trials measured fish oil against a comparison group, and found no difference when it was taken alone.
There is a second gap: dose and preparation. The 2025 network analysis rates its certainty low to moderate because of heterogeneity and imprecision, and calls for larger trials with standardised dosing and longer follow-up [7]. A person buying fish oil on the strength of the combined-treatment result is choosing a preparation, a dose and a duration that the pooled evidence does not specify.
Sources for this section: [3] Efficacy of fish oil and its components in the management of psoriasis: a systematic review of 18 randomized controlled trials · [4] Dietary Behaviors in Psoriasis: Patient-Reported Outcomes from a U.S. National Survey
Why that is not yet advice
The 2025 systematic review of dietary recommendations names omega-3 intake among the things that may be associated with better psoriasis outcomes, alongside fibre, probiotics and the Mediterranean pattern, and then states that high-quality evidence on diet and psoriasis is lacking [6]. The joint dermatology guidelines of care review alternative medicine within their scope, with the dermatologist's role framed as monitoring and educating patients on benefits and risks [2]; nothing in that guidance, as cited here, recommends fish oil. The clinical-practice review of nutrition in psoriasis, written for the clinicians who are asked this, spends its recommendations on the Mediterranean diet, calorie restriction and the conditional case for gluten [5].
The gap between a pooled positive result and a recommendation is not stubbornness. The newest synthesis rates the certainty low to moderate, says effect estimates vary by outcome, and asks for confirmatory trials with standardised dosing before more is claimed [7]. What the evidence supports saying is narrow: the only setting in which fish oil measured as doing anything for the skin was alongside conventional treatment, and the review's own conclusion is that it may have beneficial effects in that setting [3]. Whether that applies to one person's treatment is a conversation with the dermatologist who prescribed it.
Sources for this section: [2] Joint AAD-NPF guidelines of care for psoriasis · [5] Nutrition and Psoriasis: The Latest Evidence and How to Approach Nutrition in Clinical Practice · [6] Evidence-based dietary recommendations for patients with psoriasis: A systematic review
The fish is a different argument from the oil
Everything above is about capsules. Oily fish on the plate belongs to a different body of evidence: not fish trials, but a trial of a whole eating pattern that includes fish. The Mediterranean diet is the eating pattern with a randomised trial in psoriasis: sixteen weeks, dietitian-guided, a between-group improvement of -3.4 on the severity index, and nine of 19 people in the diet arm reaching a 75% reduction against none of the controls [1]. The clinical-practice review recommends that pattern for psoriasis on the strength of its anti-inflammatory effects and its cardiovascular benefits [5].
That trial tested the whole pattern, dietitian-guided, with olive oil supplied; it did not test fish on its own, and it cannot say which part of the pattern did the work [1]. So salmon, sardines, mackerel and trout are on the menu here as part of that pattern, not as a fish-oil dose, and the omega-3 comes along with them. The free seven-day psoriasis week on this site has fish at several dinners for that reason: salmon and potato salad with dill yoghurt, white fish baked in tomato and olive sauce, prawns with tomato and feta. The fish is part of a pattern with a trial; the capsule is an adjunct with a pooled result; neither was tested as a replacement for treatment, and this page does not present either as one.
Sources for this section: [1] Mediterranean Diet and Patients With Psoriasis: The MEDIPSO Randomized Clinical Trial · [5] Nutrition and Psoriasis: The Latest Evidence and How to Approach Nutrition in Clinical Practice
Sources
- Mediterranean Diet and Patients With Psoriasis: The MEDIPSO Randomized Clinical Trial
Perez-Bootello J, Berna-Rico E, Abbad-Jaime de Aragon C, et al. JAMA Dermatology. 2025;161(12):1215–1223. doi:10.1001/jamadermatol.2025.3410. Verified 16 Sept 2026. - Joint AAD-NPF guidelines of care for psoriasis
Elmets CA, Korman NJ, Prater EF, et al. Journal of the American Academy of Dermatology. 2021;84(2):432–470. doi:10.1016/j.jaad.2020.07.087. Verified 1 Sept 2026. - Efficacy of fish oil and its components in the management of psoriasis: a systematic review of 18 randomized controlled trials
Chen X, et al. Nutrition Reviews. 2020;78(10):827–840. PMID:31995220. Verified 1 Sept 2026. - Dietary Behaviors in Psoriasis: Patient-Reported Outcomes from a U.S. National Survey
Afifi L, et al. Dermatology and Therapy. 2017. PMCID:PMC5453925. Verified 1 Sept 2026. - Nutrition and Psoriasis: The Latest Evidence and How to Approach Nutrition in Clinical Practice
Leung A, Kranyak A, Marquez-Grap G, Bhutani T. American Journal of Clinical Dermatology. 2026;27:9–16. doi:10.1007/s40257-025-00992-2. Verified 1 Sept 2026. - Evidence-based dietary recommendations for patients with psoriasis: A systematic review
Wang Q, et al. Clinical Nutrition. 2025;47:68–82. doi:10.1016/j.clnu.2025.02.005. PMID:39987781. Verified 1 Sept 2026. - Effectiveness and safety of dietary supplements in the adjunctive treatment of psoriasis: a systematic review and network meta-analysis
Systematic review and network meta-analysis of 21 randomized trials. PMID:41459063. Evidence searched through March 2025. Verified 1 Sept 2026.
